Table 2a.
GMT(95%CI) |
|||
---|---|---|---|
Groups | Type I | Type II | Type III |
Full-dose sIPV | 22.90(9.50, 55.16) | 3.78(0.31, 46.41) | 3.57(0.38, 33.67) |
1/4-dose sIPV | 1.89(0.32, 11.03) | 1.00(1.00, 1.00) | 1.52(0.48, 4,81) |
1/4-dose+AS03 | 57.04(18.21, 178.65) | 67.08(11.09, 405.88) | 163.27(87.88, 303.25) |
1/4-dose+BW006 | 75.27(29.03, 195.12) | 3.48(0.35, 35.06) | 11.45(0.56, 232.81) |
1/4-dose+Poly:IC | 39.19(9.21, 166.80) | 1.00(1.00, 1.00) | 1.00(1.00, 1.00) |
1/4 dose+AS03+ BW006 | 262.12(192.84, 356.29) | 210.38(58.82, 752.66) | 163.27(52.71, 505.59) |
Total | 52.26(30.13, 90.68) | 14.49(6.46, 32.54) | 20.87(9.68, 45.00) |
Note: Full-dose referred to type = 30 DU, type II = 32 DU, type III = 45 DU. 1/4-dose referred to type I = 7.5 DU, type II = 8 DU, type III = 11.25 DU
Antibody titer of the first immunization after 28 days was expressed as geometric mean titers (GMT).